CN108210781A - It is a kind of to promote hematoblastic compound selenium Chinese herbal and crude drugs preparations - Google Patents

It is a kind of to promote hematoblastic compound selenium Chinese herbal and crude drugs preparations Download PDF

Info

Publication number
CN108210781A
CN108210781A CN201810204033.6A CN201810204033A CN108210781A CN 108210781 A CN108210781 A CN 108210781A CN 201810204033 A CN201810204033 A CN 201810204033A CN 108210781 A CN108210781 A CN 108210781A
Authority
CN
China
Prior art keywords
hematoblastic
chinese herbal
crude drugs
drugs preparations
selenium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810204033.6A
Other languages
Chinese (zh)
Inventor
程先平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201810204033.6A priority Critical patent/CN108210781A/en
Publication of CN108210781A publication Critical patent/CN108210781A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/898Orchidaceae (Orchid family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/04Sulfur, selenium or tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/486Millettia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/62Nymphaeaceae (Water-lily family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A kind of to promote hematoblastic compound selenium Chinese herbal and crude drugs preparations, the present invention relates to pharmaceutical technology fields;It is made of following weight item:12 15g of the bletilla striata, 12 15 g of rhizoma imperatae, 12 15g of charred NODUS NELUMBINIS RHIZOMATIS, 69 g of Caulis Spatholobi, 180 200 μ g of Organic Selenium.Hematoblastic quantity can significantly be increased, promote hematoblastic function, bone marrow suppression, immunosupress and other side effects etc. caused by the use simultaneously of tumor patient chemicotherapy can mitigate chemicotherapy.

Description

It is a kind of to promote hematoblastic compound selenium Chinese herbal and crude drugs preparations
Technical field
The present invention relates to pharmaceutical technology fields, and in particular to a kind of to promote hematoblastic compound selenium Chinese herbal and crude drugs preparations.
Background technology
Chinese patent drug is the rarity of world traditional medicine, the specific manifestation of Chinese achievement civilized for thousands of years, genuine Chinese medicine Huge contribution is made that with health of the experience prescription for China and the people of the world, cannot be solved in certain fields, particularly doctor trained in Western medicine Certainly or curative effect it is not good enough medical treatment and big health field have more characteristic, clinically, caused by tumour Radiotherapy chemotherapy or other a variety of causes Platelet counts are reduced and/or insufficiency is common, though and there are TPO and cell factor IL-11 class medicinal applications, a clinical efficacy Meet clinical demand with still difficulty in terms of side effect, because blood source and curative effect problem status significantly decline, blood platelet subtracts for component blood transfusion Few is still clinical problem, and without effective prevention decrease of platelet good plan.This prescription commonly uses Empirical formula, clinical verification to be clinical Using platelet counts can be obviously improved, and can enhance platelet function, the incidence of bleeding during blood platelet reduces is reduced, especially It can obviously reduce the amplitude and thrombopenia of blood platelet decline importantly, in the application of the tumor patient chemicotherapy same period Incidence, there is apparent prevention to be worth.
Human body is made of macroelement and more than ten kind trace elements, micro- but function pole atomic in people's in-vivo content Its is important, is human essential elements, can only be orally ingested, wherein, selenium is a kind of most important micro elements needed by human, research Show:A variety of chronic diseases that it lacks with Keshan disease and including tumour are related, have in the prevention of tumour chronic diseases higher Application value.Selenium application in tumor patient can mitigate the side effect of Radiotherapy chemotherapy, including the weight such as digestive tract reaction, conscience kidney Prevention of organ protection and bone marrow suppression etc. is wanted, while selenium can also clear up human internal environment, body damages caused by promoting Radiotherapy chemotherapy Immunity of organisms decline etc. caused by the reparation of wound, protection and promotion chemicotherapy.
Chinese patent medicine preparation is made in selenium, bone marrow suppression caused by chemicotherapy can be mitigated, immunosupress and other side effects Deng.
Invention content
In view of the defects and deficiencies of the prior art, the present invention intends to provide a kind of ingredient is simple, reasonable design Hematoblastic compound selenium Chinese herbal and crude drugs preparations are promoted, can significantly increase hematoblastic quantity, hematoblastic function be promoted, in tumour Bone marrow suppression, immunosupress and other side effects etc. caused by the use simultaneously of patient's chemicotherapy can mitigate chemicotherapy.
To achieve the above object, the technical solution adopted by the present invention is:It is made of following parts by weight ingredient:Bletilla striata 12- 15g, rhizoma imperatae 12-15g, charred NODUS NELUMBINIS RHIZOMATIS 12-15g, Caulis Spatholobi 6-9g, Organic Selenium 180-200 μ g.
Further, the hematoblastic compound selenium Chinese herbal and crude drugs preparations of the promotion, it is made of following parts by weight ingredient: Bletilla striata 14-15g, rhizoma imperatae 14-15g, charred NODUS NELUMBINIS RHIZOMATIS 14-15g, Caulis Spatholobi 8-9g, Organic Selenium 190-200 μ g.
Further, the hematoblastic compound selenium Chinese herbal and crude drugs preparations of the promotion, it is made of following parts by weight ingredient: Bletilla striata 12-13g, rhizoma imperatae 12-13g, charred NODUS NELUMBINIS RHIZOMATIS 12-13g, Caulis Spatholobi 6-7g, Organic Selenium 180-190 μ g.
Further, contain one kind or more in addition to selenium in the hematoblastic compound selenium Chinese herbal and crude drugs preparations of promotion Kind trace element.
The procedure of processing of the present invention is as follows:
1st, the bletilla striata, rhizoma imperatae, charred NODUS NELUMBINIS RHIZOMATIS and the Caulis Spatholobi of parts by weight, manually fried or use extraction stoste are chosen;
2nd, stoste is filtered successively, sterilized;
3rd, the Organic Selenium that microbial fermentation is crossed is added into the stoste after filtering and sterilizing, the reaction was continued at a certain temperature;
4th, will react the liquid that obtains later carry out it is filling, it is filling in Organic Selenium amount be 180-200 μ g/ agent, you can.
Further, it is filtered in the step 2 using filtering equipment.
Further, it is sterilized in the step 2 using high temperature sterilization, sterilising temp is Celsius for 1000-1500 Degree, sterilization time are 5-8 hours.
Further, fermentation temperature is 50-120 degrees Celsius in the step 3, and fermentation time is 14 days.
The present invention instructions of taking be:According to above-mentioned dosage one dose per day, take twice.
The present invention has the beneficial effect that:
1st, the effect of platelet counts can be obviously improved, being taken while chemicotherapy starts can be declined with substantially reduced blood platelet Degree and the duration, ensure chemicotherapy complete on schedule;
2nd, there are certain leucocyte promotion and immune function castering action, also certain prevention is taken while chemicotherapy starts Leucocyte declines and immanoprotection action;
3rd, start, i.e. by one dose per day, to take twice in tumor patient chemicotherapy, also there is certain interior environment liquidation value, energy Conscience injury of kidney caused by protecting chemicotherapy promotes mucous membrane and other injury repairs etc. caused by chemicotherapy.
Specific embodiment
Present embodiment(Embodiment one)The technical solution adopted is that:It is made of following parts by weight ingredient:The bletilla striata 13g, rhizoma imperatae 13g, charred NODUS NELUMBINIS RHIZOMATIS 13g, Caulis Spatholobi 7g, 190 μ g of Organic Selenium.
Further, contain one kind or more in addition to selenium in the hematoblastic compound selenium Chinese herbal and crude drugs preparations of promotion Kind trace element.
The procedure of processing of present embodiment is as follows:
1st, bletilla striata 13g, rhizoma imperatae 13g, charred NODUS NELUMBINIS RHIZOMATIS 13g, Caulis Spatholobi 7g are chosen, it is manually fried to obtain stoste;
2nd, stoste using filtering equipment is filtered, is sterilized using high temperature sterilization, sterilising temp is 1000 degrees Celsius, sterilizing Time is 8 hours;
3rd, the 190 μ g of Organic Selenium that microbial fermentation is crossed are added into the stoste after filtering and sterilizing, are continued at a certain temperature anti- Should, fermentation temperature is 110 degrees Celsius, and fermentation time is 14 days;
4th, the liquid that obtains later will be reacted to concentrate, paste is made, then the paste carried out it is filling, it is filling in it is organic Selenium amount is 190 μ g/agent, you can.
The instructions of taking of present embodiment is:According to above-mentioned dosage one dose per day, take twice.
Present embodiment has the beneficial effect that:The hematoblastic compound selenium of a kind of promotion that present embodiment provides Chinese herbal and crude drugs preparations can significantly increase hematoblastic quantity, promote hematoblastic function, can in the use simultaneously of tumor patient chemicotherapy Bone marrow suppression caused by mitigate chemicotherapy and immunosupress and other side effects etc..
Embodiment two:
The hematoblastic compound selenium Chinese herbal and crude drugs preparations of promotion described in the present embodiment, it is made of following parts by weight ingredient:In vain Splendid achnatherum 15g, rhizoma imperatae 15g, charred NODUS NELUMBINIS RHIZOMATIS 15g, Caulis Spatholobi 9g, 200 μ g of Organic Selenium.
The procedure of processing of the present embodiment is as follows:
1st, bletilla striata 15g, rhizoma imperatae 15g, charred NODUS NELUMBINIS RHIZOMATIS 15g, Caulis Spatholobi 9g are chosen, stoste is obtained through extraction;
2nd, stoste using filtering equipment is filtered, is sterilized using high temperature sterilization, sterilising temp is 1000 degrees Celsius, sterilizing Time is 7 hours;
3rd, the 200 μ g of Organic Selenium that microbial fermentation is crossed are added into the stoste after filtering and sterilizing, are continued at a certain temperature anti- Should, fermentation temperature is 100 degrees Celsius, and fermentation time is 14 days;
4th, the liquid evaporation concentration obtained later will be reacted, be made solid, then the solid carried out it is filling, it is filling in Organic Selenium It measures as 200 μ g/agent, you can.
The instructions of taking of the present embodiment is:According to above-mentioned dosage one dose per day, take twice.
Embodiment three:
The hematoblastic compound selenium Chinese herbal and crude drugs preparations of promotion described in the present embodiment, it is made of following parts by weight ingredient:In vain Splendid achnatherum 12g, rhizoma imperatae 12g, charred NODUS NELUMBINIS RHIZOMATIS 12g, Caulis Spatholobi 6g, 185 μ g of Organic Selenium.
The procedure of processing of the present embodiment is as follows:
1st, bletilla striata 12g, rhizoma imperatae 12g, charred NODUS NELUMBINIS RHIZOMATIS 12g, Caulis Spatholobi 6g are chosen, it is manually fried to obtain stoste;
2nd, stoste using filtering equipment is filtered, is sterilized using high temperature sterilization, sterilising temp is 1200 degrees Celsius, sterilizing Time is 7 hours;
3rd, the 185 μ g of Organic Selenium that microbial fermentation is crossed are added into the stoste after filtering and sterilizing, are continued at a certain temperature anti- Should, fermentation temperature is 50 degrees Celsius, and fermentation time is 14 days;
4th, will react the liquid that obtains later carry out it is filling, it is filling in Organic Selenium amount be 185 μ g/agent, you can.
The instructions of taking of the present embodiment is:According to above-mentioned dosage one dose per day, take twice.
The above is merely illustrative of the technical solution of the present invention and unrestricted, and those of ordinary skill in the art are to this hair The other modifications or equivalent replacement that bright technical solution is made, without departing from the spirit and scope of technical solution of the present invention, It is intended to be within the scope of the claims of the invention.

Claims (8)

1. a kind of promote hematoblastic compound selenium Chinese herbal and crude drugs preparations, it is characterised in that:It is made of following parts by weight ingredient:In vain Splendid achnatherum 12-15g, rhizoma imperatae 12-15g, charred NODUS NELUMBINIS RHIZOMATIS 12-15g, Caulis Spatholobi 6-9g, Organic Selenium 180-200 μ g.
2. a kind of hematoblastic compound selenium Chinese herbal and crude drugs preparations of promotion according to claim 1, it is characterised in that:Described Hematoblastic compound selenium Chinese herbal and crude drugs preparations are promoted, it is made of following parts by weight ingredient:Bletilla striata 14-15g, rhizoma imperatae 14- 15g, charred NODUS NELUMBINIS RHIZOMATIS 14-15g, Caulis Spatholobi 8-9g, Organic Selenium 190-200 μ g.
3. a kind of hematoblastic compound selenium Chinese herbal and crude drugs preparations of promotion according to claim 1, it is characterised in that:Described Hematoblastic compound selenium Chinese herbal and crude drugs preparations are promoted, it is made of following parts by weight ingredient:Bletilla striata 12-13g, rhizoma imperatae 12- 13g, charred NODUS NELUMBINIS RHIZOMATIS 12-13g, Caulis Spatholobi 6-7g, Organic Selenium 180-190 μ g.
4. a kind of hematoblastic compound selenium Chinese herbal and crude drugs preparations of promotion according to claim 1, it is characterised in that:Described It is promoted in hematoblastic compound selenium Chinese herbal and crude drugs preparations containing one or more trace elements in addition to selenium.
5. a kind of promote hematoblastic compound selenium Chinese herbal and crude drugs preparations, it is characterised in that:Its procedure of processing is as follows:
(1), the bletilla striata, rhizoma imperatae, charred NODUS NELUMBINIS RHIZOMATIS and the Caulis Spatholobi of parts by weight, manually fried or use extraction stoste are chosen;
(2), stoste is filtered successively, sterilized;
(3), the Organic Selenium that microbial fermentation is crossed is added into the stoste after filtering and sterilizing, the reaction was continued at a certain temperature;
(4), will react the liquid that obtains later carry out it is filling, it is filling in Organic Selenium amount be 180-200 μ g/ agent, you can.
6. a kind of hematoblastic compound selenium Chinese herbal and crude drugs preparations of promotion according to claim 1, it is characterised in that:Described It is filtered in step (2) using filtering equipment.
7. a kind of hematoblastic compound selenium Chinese herbal and crude drugs preparations of promotion according to claim 1, it is characterised in that:Described It is sterilized in step (2) using high temperature sterilization, sterilising temp is 1000-1500 degrees Celsius, and sterilization time is 5-8 hours.
8. a kind of hematoblastic compound selenium Chinese herbal and crude drugs preparations of promotion according to claim 1, it is characterised in that:Described Fermentation temperature is 50-120 degrees Celsius in step (3), and fermentation time is 14 days.
CN201810204033.6A 2018-03-13 2018-03-13 It is a kind of to promote hematoblastic compound selenium Chinese herbal and crude drugs preparations Pending CN108210781A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810204033.6A CN108210781A (en) 2018-03-13 2018-03-13 It is a kind of to promote hematoblastic compound selenium Chinese herbal and crude drugs preparations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810204033.6A CN108210781A (en) 2018-03-13 2018-03-13 It is a kind of to promote hematoblastic compound selenium Chinese herbal and crude drugs preparations

Publications (1)

Publication Number Publication Date
CN108210781A true CN108210781A (en) 2018-06-29

Family

ID=62658424

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810204033.6A Pending CN108210781A (en) 2018-03-13 2018-03-13 It is a kind of to promote hematoblastic compound selenium Chinese herbal and crude drugs preparations

Country Status (1)

Country Link
CN (1) CN108210781A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1557390A (en) * 2004-01-13 2004-12-29 合肥恒星药物研究所 Chinese traditional medicine for treating thrombocytopenia

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1557390A (en) * 2004-01-13 2004-12-29 合肥恒星药物研究所 Chinese traditional medicine for treating thrombocytopenia

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
于作洋等: "《国医大家刘弼臣学术经验集成》", 31 January 2013, 中国中医药出版社 *
谭恩广: "《毛南族医药》", 30 November 2007, 广西民族出版社 *
邓舜扬: "《功能性食品与保健》", 31 August 2006, 科学技术文献出版社 *

Similar Documents

Publication Publication Date Title
CN102552775B (en) Antiseptic solution
US20060269567A1 (en) Universal detoxifying composition
CN101612290B (en) Medicinal composition for treating burn and scald and preparation method thereof
CN104971161A (en) Application of vine tea extract in treatment of acnes
CN204033810U (en) Phlegm storage cup
CN102552663A (en) Chinese herbal compound used for treating paraquat poisoning
CN108210781A (en) It is a kind of to promote hematoblastic compound selenium Chinese herbal and crude drugs preparations
CN104257795A (en) Medicine for treating cold
CN103127473A (en) Pain-relieving paste
CN101612203B (en) Traditional Chinese medicine composition used for treating pointed condyloma and application thereof
CN103585330B (en) A kind of Chinese medicine composition for cutaneous fungal infection and preparation method thereof
CN103705650A (en) Chinese herbal medicinal compound bee venom liniment preparation method
CN102210812B (en) Compound Retapamulin medicinal membrane agent and preparation method thereof
CN101204414A (en) Pasty medicine for treating asthma
CN111317793A (en) Medicine composition for preventing and treating dry cough type influenza and application method thereof
CN105079141A (en) Tibetan veterinary medicine combination for treating yak pneumonia and preparation method and application thereof
CN105079590A (en) Traditional Chinese medicine for treating non-specific ulcerative colitis
CN103623007A (en) Externally-applied ointment for treating ringworm of scalp and preparation and application methods thereof
CN103610965B (en) Medicament for treating heart blood stasis type thoracic obstruction
CN102764289A (en) Externally applied medicine for treating single poisonous wasp sting
CN102343062A (en) Traditional Chinese medicine for treating gastric hyperacidity
CN103908566A (en) A traditional Chinese medicine medicament used for treating chronic atrophic gastritis and a preparing method thereof
CN101254229B (en) Medicament preventing and treating viral infection of upper respiratory tract and method of preparing the same
CN101204452B (en) Tincture medicine for verruca plana
CN101843683B (en) Inflammation-diminishing and muscle-growing oil

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20180629

RJ01 Rejection of invention patent application after publication